“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...
The restructuring arrives during a period of turmoil at South San Francisco-based 23andMe, which has recently included a high ...
Genetics testing company 23andMe is trimming its headcount by 40%. The company said it is undergoing a restructuring to ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
Regarding its workforce reduction, which will total 200 employees, CEO Anne Wojcicki called the layoffs a “difficult but necessary” step to keep the company alive. “We are taking these difficult ...
Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...
Anne Wojcicki wanted to run things—alone. It was 2009 and her startup 23andMe was riding high, fueled by a steady stream ...
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
The struggling genetic testing company 23andMe says it will cut 40% of its workforce, or 200 jobs, as it fights for survival.